Home › Funds › Granahan Investment Management, LLC › RGEN

Granahan Investment Management, LLC position in RGEN

REPLIGEN CORP · Health Care

Granahan Investment Management, LLC reported holding 276,640 shares of RGEN (REPLIGEN CORP) in its Q3 2026 13F filing — a position valued at US$53.2M, representing 2.34% of its reported portfolio and ranking #8 among its reported holdings. Granahan Investment Management, LLC has disclosed RGEN holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)276.64K sh
Reported value held$53.18M
Portfolio Weight2.34%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Granahan Investment Management, LLC's RGEN position evolved

Granahan Investment Management, LLC first disclosed a stake in RGEN in Q3 2023 at 132,758 shares (US$21.1M). The position peaked in Q3 2026 at 276,640 shares, worth US$53.2M. Across 12 filings, Granahan Investment Management, LLC increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 276,640 shares valued at US$53.2M — a reduction of -55,631 shares quarter over quarter.. Notable position changes include a 33% increase in Q2 2025 (shares rose 7% over the following quarter), a 48% trim in Q3 2025 (shares rose 23% over the following quarter), a 282% increase in Q2 2026 (shares rose 41% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 132.76K $21.11M New
Q4 2023 129.69K $23.32M Reduce
Q1 2024 124.77K $22.95M Reduce
Q3 2024 88.25K $13.13M New
Q4 2024 107.42K $15.46M Add
Q1 2025 101.20K $12.88M Reduce
Q2 2025 135.05K $16.80M Add
Q3 2025 69.87K $9.34M Reduce
Q4 2025 72.00K $11.80M Add
Q1 2026 86.95K $10.24M Add
Q2 2026 332.27K $45.34M Add
Q3 2026 276.64K $53.18M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGEN and 13F data

RGEN (REPLIGEN CORP) is a Health Care company. 35 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$536.3M), Maverick Capital (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGEN

All RGEN fund holders →

FAQ

How long has Granahan Investment Management, LLC held RGEN?

Granahan Investment Management, LLC has disclosed RGEN holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

What is Granahan Investment Management, LLC's current position in RGEN?

As of Q3 2026, Granahan Investment Management, LLC holds 276.64K shares of RGEN (REPLIGEN CORP), valued at $53.18M, representing 2.34% of its reported portfolio and ranking #8.

Has Granahan Investment Management, LLC been buying or selling RGEN?

In the latest 13F filing (Q3 2026), Granahan Investment Management, LLC reduced its position in RGEN. The position peaked in Q3 2026 at 276.64K shares.

Which other funds hold RGEN?

Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick Capital, MAVERICK CAPITAL LTD, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.